Navigation Links
Chindex International, Inc. Reports Financial Results for the Three and Nine Month Period Ended December 31, 2010
Date:3/15/2011

- basic

16,036,825

14,592,992

15,347,173

14,533,601Net income per common share - diluted

$.10

$.24

$.36

$.48Weighted average shares outstanding - diluted

17,362,919

16,211,607

16,703,670

16,127,180CHINDEX INTERNATIONAL, INC.CONSOLIDATED CONDENSED BALANCE SHEETS(in thousands except share data)December 312010March 312010ASSETSCurrent assets:Cash and cash equivalents

$32,007

$50,654Restricted cash

300

468Investments

37,631

37,207Receivables from affiliates

9,330

-   Accounts receivable, less allowance for doubtful accounts of $6,748 and $6,158, respectivelyProduct sales receivables

-

22,760Patient service receivables

11,601

10,357Inventories, net

1,413

14,411Deferred income taxes

3,242

2,843Other current assets

3,856

3,032Total current assets

99,380

141,732Restricted cash

980

2,556Investments

2,439

-Investment in unconsolidated affiliate

31,756

-Property and equipment, net

37,099

23,678Noncurrent deferred income taxes

108

103Other assets

2,411

2,774Total assets

$174,173

$170,843LIABILITIES AND STOCKHOLDERS' EQUITYCurrent liabilities:Short-term debt, current portion of long-term debt and vendor financing

$-

$1,453Accounts payable

4,038

13,979Accrued expenses

8,541

14,022Other current liabilities

3,874

3,826Deferred revenue

-

2,549Income taxes payable

2,147

2,218Total current liabilities

18,600

38,047Long-term debt, vendor financing and convertible debentures

23,070

22,593Long-term accrued liabilities

-

84Long-term deferred revenue

-'/>"/>

SOURCE Chindex International, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10

Related medicine technology :

1. Chindex International to Report Financial Results for the Three and Nine-Month Periods Ended December 31, 2010
2. Chindex and Fosun Pharma Form Joint Venture
3. Chindex International, Inc. Reports Second Quarter and First Half Fiscal 2011 Financial Results
4. Fosun Pharma Acquires $14 Million of Chindex Stock
5. Chindex International to Report First Quarter 2011 Financial Results
6. Chindex International, Inc. Reports Fourth Quarter and Full Year Fiscal 2010 Financial Results
7. Chindex International to Report Third Quarter Fiscal Year 2010 Financial Results
8. Chindex International to Present at Piper Jaffray Health Care Conference
9. Chindex International Announces Participation in Brean Murray, Carret & Co. 2009 China Growth Conference
10. Chindex International, Inc. Reports Second Quarter and First Half Fiscal 2010 Financial Results
11. Chindex International, Inc. to Report Second Quarter Fiscal 2010 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/24/2013)... 2013 In accordance with Rule 17.1 and Rule ... the United States Exchange Act, Echo Pharma Acquisition Limited ("Royalty ... Corporation (NYSE: ELN). Background On 2 ... offer for the entire of the issued and to be ... Offer").  On 20 May 2013, Royalty Pharma ...
(Date:5/23/2013)... WASHINGTON , May 23, 2013  Vanda Pharmaceuticals Inc. ... company has been named the 2013 Life Science Firm of ... (TCM).  Vanda was honored at the TCM,s 25 ... Bethesda , Maryland.  The Tech Awards Celebration recognizes the ... in Maryland and the surrounding regions. ...
(Date:5/23/2013)... 2013 Nephros, Inc. (OTC Bulletin Board: ... that develops and sells high performance liquid purification ultrafilters, ... In addition, the concurrent temporary reduction in exercise price ... 17, 2013. Nephros estimates that it will ... offering.   A portion of the proceeds will be used ...
Breaking Medicine Technology:Royalty Pharma Discloses Acceptance Levels of Original Offer for Elan Pursuant to Irish and United States Regulatory Requirements 2Royalty Pharma Discloses Acceptance Levels of Original Offer for Elan Pursuant to Irish and United States Regulatory Requirements 3Royalty Pharma Discloses Acceptance Levels of Original Offer for Elan Pursuant to Irish and United States Regulatory Requirements 4Royalty Pharma Discloses Acceptance Levels of Original Offer for Elan Pursuant to Irish and United States Regulatory Requirements 5Royalty Pharma Discloses Acceptance Levels of Original Offer for Elan Pursuant to Irish and United States Regulatory Requirements 6Royalty Pharma Discloses Acceptance Levels of Original Offer for Elan Pursuant to Irish and United States Regulatory Requirements 7Royalty Pharma Discloses Acceptance Levels of Original Offer for Elan Pursuant to Irish and United States Regulatory Requirements 8Royalty Pharma Discloses Acceptance Levels of Original Offer for Elan Pursuant to Irish and United States Regulatory Requirements 9Vanda Pharmaceuticals Named the 2013 Life Science Firm of the Year by the Tech Council of Maryland 2Nephros Announces Completion of Rights Offering 2Nephros Announces Completion of Rights Offering 3Nephros Announces Completion of Rights Offering 4
... Pharmaceuticals, Inc. (NASDAQ: OPTR ) announced today ... antibiotics in two Phase 3 clinical trials exploring the ... adult patients with Clostridium difficile -associated diarrhea (CDAD) ... Clinical Infectious Diseases (CID). The analysis found ...
... 2011 /PRNewswire-Asia-FirstCall/ -- China Medical Technologies, ... CMED ), a leading China-based advanced ... unaudited financial results for the first ... ("1Q FY2011") today.1 Q FY20 ...
Cached Medicine Technology:Clinical Infectious Diseases Publishes Subgroup Analysis Showing Optimer's DIFICID™ (fidaxomicin) Tablets Exhibited Higher Clinical Cure and Global Cure Rates Than Vancomycin in Patients with Clostridium difficile-Associated Diarrhea (CDAD) Receivin 2Clinical Infectious Diseases Publishes Subgroup Analysis Showing Optimer's DIFICID™ (fidaxomicin) Tablets Exhibited Higher Clinical Cure and Global Cure Rates Than Vancomycin in Patients with Clostridium difficile-Associated Diarrhea (CDAD) Receivin 3Clinical Infectious Diseases Publishes Subgroup Analysis Showing Optimer's DIFICID™ (fidaxomicin) Tablets Exhibited Higher Clinical Cure and Global Cure Rates Than Vancomycin in Patients with Clostridium difficile-Associated Diarrhea (CDAD) Receivin 4Clinical Infectious Diseases Publishes Subgroup Analysis Showing Optimer's DIFICID™ (fidaxomicin) Tablets Exhibited Higher Clinical Cure and Global Cure Rates Than Vancomycin in Patients with Clostridium difficile-Associated Diarrhea (CDAD) Receivin 5Clinical Infectious Diseases Publishes Subgroup Analysis Showing Optimer's DIFICID™ (fidaxomicin) Tablets Exhibited Higher Clinical Cure and Global Cure Rates Than Vancomycin in Patients with Clostridium difficile-Associated Diarrhea (CDAD) Receivin 6China Medical Technologies Reports First Fiscal Quarter Financial Results 2China Medical Technologies Reports First Fiscal Quarter Financial Results 3China Medical Technologies Reports First Fiscal Quarter Financial Results 4China Medical Technologies Reports First Fiscal Quarter Financial Results 5China Medical Technologies Reports First Fiscal Quarter Financial Results 6China Medical Technologies Reports First Fiscal Quarter Financial Results 7China Medical Technologies Reports First Fiscal Quarter Financial Results 8China Medical Technologies Reports First Fiscal Quarter Financial Results 9China Medical Technologies Reports First Fiscal Quarter Financial Results 10China Medical Technologies Reports First Fiscal Quarter Financial Results 11China Medical Technologies Reports First Fiscal Quarter Financial Results 12China Medical Technologies Reports First Fiscal Quarter Financial Results 13China Medical Technologies Reports First Fiscal Quarter Financial Results 14China Medical Technologies Reports First Fiscal Quarter Financial Results 15China Medical Technologies Reports First Fiscal Quarter Financial Results 16China Medical Technologies Reports First Fiscal Quarter Financial Results 17China Medical Technologies Reports First Fiscal Quarter Financial Results 18China Medical Technologies Reports First Fiscal Quarter Financial Results 19
(Date:5/24/2013)... KC and Monica Craichy, Founders of ... Their oldest sons, Kyle and Austin Craichy, will be kiteboarding ... several professional kiteboarders. , KC Craichy said he is excited ... come together such that virtually everyone who planned to be ... kite boarders will meet at Matheson Hammock Park and Beach ...
(Date:5/24/2013)... Mirena IUD lawyers at the Rottenstein Law Group ... more than 59,229 complaints since 2004 from women claiming they ... known as the Mirena IUD.* , Among the most common ... ‘expulsion,’ where the IUD came out on its own. There ... News article. “Abdominal pain is also common, with 3,774 complaints. ...
(Date:5/24/2013)... Denver, CO (PRWEB) May 24, 2013 ... SEO analysis, in partnership with JD Media Surge, a ... , The dental SEO analysis service will focus ... high in the search engines for their competitive keywords. ... the dentists website and recommendations based on what their ...
(Date:5/24/2013)... 24, 2013 Gift Card Network ... competitors in sustainable card material, are combining forces ... materials as a sustainable gift card substrate. , ... industry challenges and increase education and usage of ... support the reduction of carbon footprint and environmental ...
(Date:5/24/2013)... 24, 2013 Started in 1982, AMTC’s SHINE ... Orlando. 2013 marks AMTC’s 31st anniversary. SHINE is a ministry ... supermodel Millie Lewis and her daughter, Carey Lewis Arban. , ... casting directors, and music professionals including the New York Film ... Media. They are kings of Hollywood and Christian casting directors. ...
Breaking Medicine News(10 mins):Health News:FreeRide836 Sponsor Living Fuel, The Leader in Superfood Nutrition, Announces Kiteboard Launch For This Sunday To Raise Money For Orphans In Africa 2Health News:FreeRide836 Sponsor Living Fuel, The Leader in Superfood Nutrition, Announces Kiteboard Launch For This Sunday To Raise Money For Orphans In Africa 3Health News:Sufferers of Alleged Mirena IUD Side Effects Lodge More Than 59,000 Complaints With FDA, Rottenstein Law Group LLP Notes 2Health News:Dental SEO Analysis Launched by E-Dentists.com in Partnership with JD Media Surge 2Health News:Making Gift Cards Greener- Competitors Combine Efforts to Educate and Empower Merchants 2Health News:Making Gift Cards Greener- Competitors Combine Efforts to Educate and Empower Merchants 3Health News:AMTC’s Summer SHINE Event Coming to Orlando’s Luxurious Gaylord Palms July 2-7, 2013 2
... studies that was presented yesterday at Digestive Disease Week? ... compounds can sustain relief for these patients with symptoms ... to review the therapeutic benefits for irritable bowel syndrome ... of the bowel disorders like IBS and Crohn's disease ...
... surgeon Dr Jerome Blanchard who had removed the wrong kidney ... , ,The disciplinary hearing was told yesterday that ... a patient and left her dependent on dialysis, as he ... Blanchard took out his patient’s transplant kidney, which was still ...
... says that each time an elderly person falls at ... two days of crew time.// ,Significant numbers ... suggesting that these facilities are relying on ambulance services ... calls for falls made to the ambulance service in ...
... on 100 soft drinks and beverages by the FDA (Food ... the presence of benzene//, a carcinogen in much higher amount ... ,FDA had alerted these companies, and they had ... done so. Though environmental companies had expressed concern regarding this, ...
... facility for the Medical Linear Accelerator (LINAC) here under ... (DIT). ,The Society for Applied Microwave Electronics ... which pioneered the development of an indigenous Medical LINAC, ... a cost of Rs 24.88 crore, DIT Secretary D ...
... such as gastric bypass and laparoscopic reflux ... reflux// disease respectively, are becoming popular, highlights ... Week, which represents the largest gathering of ... such as gastroenterology, endoscopy, gastrointestinal surgery and ...
Cached Medicine News:Health News:New compounds Help Sustain relief For Patients With Symptoms of Bowel Disorders 2Health News:New compounds Help Sustain relief For Patients With Symptoms of Bowel Disorders 3Health News:Consultant Bungles A Kidney Surgery 2Health News:Soda Drinks Contain Benzene - A Carcinogen, Reports FDA 2Health News:Soda Drinks Contain Benzene - A Carcinogen, Reports FDA 3Health News:Gastric Bypass And Laparoscopic Reflux Surgery Gaining Popularity 2Health News:Gastric Bypass And Laparoscopic Reflux Surgery Gaining Popularity 3
Hydrophobic PE filter without self-sealing additives, permits sample recovery after accidental over-pipetting. All filters are sterile (to USP, DAB, Ph.Eur. standards) and PCR clean (free from human ...
... Finntip Filters are ideal ... methods, or for any work ... They are designed for pipetting ... samples, and other. For applications ...
... ART Aerosol Resistant Tips offer a safe ... Tips are designed for applications such as ... In addition, ART Tips are excellent for ... forensic studies. ART Tips prevent aerosol contaminants ...
200 L, Racked, Filtered, Pre-sterilized, 96 tips/rack Recommended for 20, 25, 50, 100 and 200 L pipettes. Can also be used with 300 L pipettes when pipetting 200 L or less....
Medicine Products: